Discover the issues concerning tissue-biomarker development and the hurdles faced in reaching the goal of truly personalized medicine.
Browsing: diagnostic biomarker
Evaluation of T1/T2 ratios in a pilot study as a potential biomarker of biopsy: proven benign and malignant breast lesions in correlation with histopathological disease stage
In this research article discover the potential role of quantitative MRI (qMRI) utilizing T1/T2 ratios to differentiate benign from malignant breast lesions.
In this patient perspective article, you can find out about the challenges associated with diagnosing mesothelioma and the promising role that biomarkers are playing.
In this review article the authors highlight how nanotechnology could help enhance cancer diagnosis.
Metabolomic profiling could allow identification of cancer subtypes and precision therapy.
Could newly uncovered genetic markers for prostate-specific antigen improve screening for prostate cancer?
Researchers have uncovered genetic markers that account for natural variation in the levels of prostate-specific antigen among men; these findings could improve accuracy when screening for prostate cancer.
Diagnostic significance of circulating multiple miRNAs in breast cancer: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to assess whether circulating multiple miRNAs can be used as novel biomarkers for the diagnosis of breast cancer.
New tumor classification tool that examines DNA methylation profiles shows promise in diagnosing tumors of unknown origin.
Experts in the field Thomas Schlange and Klaus Pantel detail their thoughts on how liquid biopsy by CTCs may improve our ability to monitor malignancies and predict treatment efficacy in this editorial from Pharmacogenomics.
This primary research article from Biomarkers in Medicine investigates the diagnostic potential of FGFR3/Cyclin D3 urinary protein levels in detecting bladder cancer recurrence.